Insilico Medicine

AI-driven drug discovery company founded in 2014 and headquartered in Hong Kong with global R&D centers. Insilico integrates generative AI, target identification, and small-molecule design into an end-to-end platform. The company advances its own pipeline (fibrosis, oncology, immunology) while partnering with major pharma firms. Insilico is recognized for pioneering AI-designed drugs entering clin...